Results 81 to 90 of about 11,687 (218)
Preventing First and Further Decompensation in Advanced Chronic Liver Disease
ABSTRACT Advanced chronic liver disease (ACLD) remains a major cause of global morbidity and mortality. Preventing hepatic decompensation—both the first event and subsequent recurrences—has become a central therapeutic goal to prolong survival. The transition from the compensated phase (cACLD) to the decompensated phase (dACLD) is driven by clinically ...
Leonardo Corrêa Süffert +2 more
wiley +1 more source
Esophagojejunal varices occurring after total gastrectomy are rare but potentially fatal in cases of variceal bleeding. Owing to their rarity, treatment strategies for this condition are not well established.
Sang Un Kim, MD, Jihoon Hong, MD
doaj +1 more source
Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? [PDF]
Porto sinusoidal vascular liver disease (PSVD) and portal vein thrombosis (PVT) are distinct vascular liver diseases characterized, respectively, by an intrahepatic and a prehepatic obstacle to the flow in the liver portal system. PVT may also occur as a
D'Amati, G. +4 more
core +1 more source
ABSTRACT Background and Aims Extrahepatic portal vein obstruction (EHPVO) is among the main causes of childhood portal hypertension. We analysed nationwide long‐term outcomes of EHPVO in relation to various management options. Methods In total, 62 consecutive patients with EHPVO diagnosed between 1987 and 2023 were followed up through hospital records ...
Topi Luoto +2 more
wiley +1 more source
Objectives Transjugular intrahepatic portosystemic shunt (TIPS) is a catheter-based, minimally invasive procedure to reduce portal hypertension. The aim of the study was to investigate dysfunction and mortality after TIPS and to identify factors ...
Laura Büttner +11 more
doaj +1 more source
We are all trying to predict what we don’t know!
The current issue of Annals of Hepatology has multiple articles trying to predict different aspects of liver disease: steatohepatitis in non-alcoholic fatty liver disease (NAFLD), steatosis and fibrosis in hepatitis C virus (HCV) infected patients ...
Kevork M. Peltekian
doaj +1 more source
Pathophysiological and clinical approach to cirrhotic cardiomyopathy. [PDF]
Hyperdynamic circulation, systolic and diastolic left ventricular dysfunction and certain electrophysiological abnormalities have been associated with cirrhosis and known for a long time.
Czifra, Árpád +5 more
core
Continuous Infusion of Pantoprazole with Octreotide Does Not Improve Management of Variceal Hemorrhage [PDF]
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90065/1/phco.29.3.248 ...
Alaniz, Cesar +2 more
core +1 more source
ABSTRACT Background and Aims Long‐term albumin (LTA) is effective for treating ascites in decompensated cirrhosis. This study aims to analyse the clinical courses of patients receiving LTA and provide a 3 month stratification to personalise management integrating LTA with other options.
Enrico Pompili +18 more
wiley +1 more source
We report successful management of transjugular intrahepatic portosystemic shunt stent infection (endotipsitis) following direct intrahepatic portocaval shunt for chronic Budd–Chiari syndrome. PETCT confirmed FDG-avid vegetation/thrombus within the stent
Nischal G. Kundaragi +3 more
doaj +1 more source

